冠状动脉微血管功能障碍诊断方法的研究进展

doi:10.3969/j.issn.1007-9572.2016.26.023

摘要/Abstract

摘要： 　　冠状动脉微血管在心肌血供中起重要作用，其功能障碍会导致不同程度的冠状动脉疾病，尤其是冠心病，如急性心肌梗死急诊介入术后无复流/慢血流现象、微血管性心绞痛等。随着现代医学的发展，新的影像技术可以清晰显示心外膜冠状动脉，但对微小冠状动脉却无能为力。准确发现冠状动脉微血管功能障碍对指导心血管疾病治疗，改善患者症状及预测预后有着积极的意义。近些年涌现了许多评价冠状动脉微血管功能障碍的方法，尚无金标准，本文现将这些诊断方法的研究进展综述如下。

关键词: 冠状动脉循环, 微血管, 诊断, 综述

Abstract: Coronary microcirculation system plays an important role in myocardial blood flow,and its dysfunction may result in different degrees of coronary artery disease especially coronary heart disease,such as acute myocardial infarction with no or slow re-flow during emergency percutaneous interventional therapy and microvascular angina.The development of modern medicine has allowed new imaging technology to clearly display epicardial coronary arteries,but such technology cannot detect significantly small coronary arteries.Accurate discovery of coronary microvascular dysfunction is important for guiding cardiovascular disease treatment,improving clinical symptoms,and predicating prognosis.In recent years,many methods have been used to evaluate coronary microcirculation function,but none of these methods has been adopted as a golden standard.The present study reviews the research progress of these diagnosis methods.

Key words: Coronary circulation, Microvessels, Diagnosis, Review

徐冰, 何胜虎, 徐日新, 谢勇, 纪军, 廖清池, 邓敏, 程铖. 冠状动脉微血管功能障碍诊断方法的研究进展[J]. 中国全科医学, 2016, 19(26): 3238-3242.

XU Bing, HE Sheng-hu, XU Ri-xin, XIE Yong, JI Jun, LIAO Qing-chi, DENG Min, CHENG Cheng. Research Progress of Diagnostic Methods of Coronary Microvascular Dysfunction[J]. Chinese General Practice, 2016, 19(26): 3238-3242.

参考文献

［1］CREA F，LANZA G A，CAMICI P G.Coronary microvascular dysfunction［M］.Milan:Springer，2014:3-4. ［2］LANZA G A，CREA F.Primary coronary microvascular dysfunction:clinical presentation，pathophysiology，and management ［J］.Circulation，2010，121（21）:2317-2325. ［3］CREA F，CAMICI P G，BAIREY MERZ C N.Coronary microvascular dysfunction:an update ［J］.Eur Heart J，2014，35（17）:1101-1111. ［4］KARMPALIOTIS D，TURAKHIA M P，KIRTANE A J，et al.Sequential risk stratification using TIMI risk score and TIMI flow grade among patients treated with fibrinolytic therapy for ST-segment elevation acute myocardial infarction ［J］.Am J Cardiol，2004，94（9）:1113-1117. ［5］GIBSON C M，CANNON C P，MURPHY S A，et al.Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs ［J］.Circulation，2000，101（2）:124-130. ［6］GIBSON C M，CANNON C P，MURPHY S A，et al.Relationship of the TIMI myocardial perfusion grades，flow grades，frame count，and percutaneous coronary intervention to long-term outcomes after thrombolytic administration in acute myocardial infarction ［J］.Circulation，2002，105（16）:1909-1913. ［7］ZALEWKI J，ZMUDKA K，MUSIALEK P，et al.Detection of microvascular injury by evaluating epicardial blood flow in early reperfusion following primary angioplasty ［J］.Int J Cardiol，2004，96（3）:389-396. ［8］JESPERSEN L，ABILDSTRM S Z，PEA A，et al.Predictive value of the corrected TIMI frame count in patients with suspected angina pectoris but no obstructive coronary artery disease at angiography ［J］.Clin Res Cardiol，2014，103（5）:381-387. ［9］GIBSON C M，CANON C P，DALEY W L，et al.TIMI frame count:a quantitative method of assessing coronary artery flow ［J］.Circulation，1996，93（5）:879-888. ［10］GIBSON C M，SCHMIG A.Coronary and myocardial angiography:angiographic assessment of both epicardial and myocardial perfusion ［J］.Circulation，2004，109（25）:3096-3105. ［11］VRACHATIS A D，ALPERT M A，GEORGULAS V P，et al.Comparative efficacy of primary angioplasty with stent implantation and thrombolysis in restoring basal coronary artery flow in acute ST segment elevation myocardial infarction:quantitative assessment using the corrected TIMI frame count ［J］.Angiology，2001，52（3）:161-166. ［12］APPLEBY M A，MICHASELS A D，CHEN M，et al.Importance of the TIMI frame count:implications for future trials ［J］.Curr Control Trials Cardiovasc Med，2000，1（1）:31-34. ［13］STOEL M G，DE COCK C C，SPRUIJT H J，et al.Corrected TIMI frame count and frame count velocity ［J］.Neth Heart J， 2003，11（3）:109-112. ［14］FERNANDES D R，TSUTSUI J M，BOCCHI E A，et al.Qualitative and quantitative real time myocardial contrast echocardiography for detecting hibernating myocardium［J］.Echocardiography，2011，28（3）:342-349. ［15］KAUL S.Evaluating the’no reflow’phenomenon with myocardial contrast echocardiography ［J］.Basic Res Cardiol，2006，101（5）:391-399. ［16］SHAH B N，CHAHAL N S，BHATTACHARYYA S，et al.The feasibility and clinical utility of myocardial contrast echocardiography in clinical practice:results from the incorporation of myocardial perfusion assessment into clinical testing with stress echocardiography study［J］.J Am Soc Echocardioqr，2014，27（5）:520-530. ［17］RINKEVICH D，BELCIK T，GUPTA N C，et al.Coronary autoregulation is abnormal in syndrome X:insight using myocardial contrast echocardiography［J］.J Am Soc Echocardiogr，2013，26（3）:290-296. ［18］ANAQNOSTOPOULOS C，GEORQAKOPOULOS A，PIANOU N，et al.Assessment of myocardial perfusion and viability by positron emission tomography［J］.Int J Cardiol，2013，167（5）:1737-1749. ［19］DE VRIES J，DE JONGSTE M J，JESSURUN G A，et al.Myocardial perfusion quantification in patients suspected of cardiac syndrome X with positive and negative exercise testing:a［13N］ammonia positron emission tomography study［J］.Nucl Med Commun，2006，27（10）:791-794. ［20］KNAAPEN P，GERMANS T，CAMICI P G，et al.Determinants of coronary microvascular dysfunction in symptomatic hypertrophic cardiomyopathy［J］.Am J Physiol Heart Circ Physiol，2008，294（2）:H986-993. ［21］HIGUCHI T，ABLETSHAUSER C，NEKOLLA S G，et al.Effect of the angiotensin receptor blocker Valsartan on coronary microvascular flow reserve in moderately hypertensive patients with stable coronary artery disease［J］.Microcirculation，2007，14（8）:805-812. ［22］NAGAO M，MATSUOKA H，KAWAKAMI H，et al.Detection of myocardial ischemia using 64-slice MDCT ［J］.Circ J，2009，73（5）:905-911. ［23］WATABE H，SATO A，NISHINA H，et al.Enhancement patterns detected by multidetector computed tomography are associated with microvascular obstruction and left ventricular remodeling in patients with acute myocardial infarciton［J］.Eur Heart J，2016，37（8）：684-692. ［24］GOTSCHY A，NIEMANN M，KOZERKE S，et al.Cardiovascular magnetic resonance for the assessment of coronary artery disease ［J］.Int J Cardiol，2015，193:84-92. ［25］WONG D T，LEUNG M C，RICHARDSON J D，et al.Cardiac magnetic resonance derived late microvascular obstruction assessment post ST-segment elevation myocardial infarction is the best predictor of left ventricular function:a comparison of angiographic and cardiac magnetic resonance derived measurements ［J］.Int J Cardiovasc Imaging，2012，28（8）:1971-1981. ［26］陈韵岱.女性冠状动脉微血管病变的诊断和治疗［J］.心血管病学进展，2012，33（5）：559-562. CHEN Y D.The diagnosis and treatment of women with coronary microvascular dysfunction ［J］.Advances in Cardiovascular Diseases，2012，33（5）：559-562. ［27］TAQUETI V R，RIDKER P M.Inflammation，coronary flow reserve，and microvacular dysfunction:moving beyongd cardiac syndrome X ［J］.JACC Cardiovasc Imaging，2013，6（6）:668-671. ［28］陈章炜，钱菊英.冠状动脉微循环的功能评价［J］.中华心血管病杂志，2008，36（3）:276-279. CHEN Z W，QIAN J Y.Functional evaluation of coronary microcirculation ［J］.Chinese Journal of Cardiology，2008，36（3）:276-279. ［29］HARALDSSON I，GAN L M，SVEDLUND S，et al.Non-invasive evaluation of coronary flow reserve with transthoracic Doppler echocardiography predicts the presence of significant stenosis in coronary arteries ［J］.Int J Cardiol，2014，176（1）:294-297. ［30］HILDICK-SMITH D J，MARYAN R，SHAPIRO L M.Assessment of coronary flow reserve by adenosine transthoracic echocardiography:validation with intracoronary Doppler［J］.J Am Soc Echocardiogr，2002，15（9）:984-990. ［31］KAWATA T，DAIMON M，HASEGAWA R，et al.Prognostic value of coronary flow reserve assessed by transthoracic Doppler echocardiography on long-term outcome in asymptomatic patients with type 2 diabetes without overt coronary artery disease［J］.Cardiovasc Diabetol，2013，12:121. ［32］NISHINO M，HOSHIDA S，EGAMI Y，et al.Coronary flow reserve by contrast enhanced transesophageal coronary sinus Doppler measurements can evaluate diabetic microvascular dysfunction［J］.Circ J，2006，70（11）:1415-1420. ［33］YOUN H J，PARK C S，MOON K W，et al.Relation between Duke treadmill score and coronary flow reserve using transesophageal Doppler echocardiography in patients with microvascular angina［J］.Int J Cardio，2005，98（3）:403-408. ［34］郭雨龙，郭丽君.心肌微循环及微循环阻力指数研究近况［J］.中国介入心脏病学杂志，2013，21（6）:393-395. ［35］KOBAYASHI Y，FEARON W F.Invasive coronary microcirculation assessment-current status of index of microcirculatory resistance［J］.Circ J，2014，78（5）:1021-1028. ［36］NQ M K，YONG A S，HO M，et al.The index of microcirculatory resistance predicts myocardial infarction related to percutaneous coronary intervention［J］.Circ Cardiovasc Interv，2012，5（4）:515-522. ［37］FEARON W F，LOW A F，YONG A S，et al.Prognostic value of the index of microcirculatory resistance measured after primary percutaneous coronary intervention［J］.Circulation，2013，127（24）:2436-2441. ［38］HOOLE S P，JAWORSKI C，BROWN A J，et al.Serial assessment of the index of microcirculatory resistance during primary percutaneous coronary intervention comparing manual aspiration catheter thrombectomy with balloon angioplasty（IMPACT study）:a randomised controlled pilot study ［J］.Open Heart，2015，2（1）：e000238. ［39］PARK S D，BAEK Y S，LEE M J，et al.Comprehensive assessment of microcirculation after primary precutaneous intervention in ST-segment elevation myocardial infarction:insight from thermodilution-derived index of microcirculatory resistance and coronary flow reserve ［J］.Coron Artery Dis，2016，27（1）:34-39. ［40］YOO S H，YOO T K，LIM H S，et al.Index of microcirculatory resistance as predictor for microvascular functional recovery in patients with anterior myocardial infarction ［J］.J Korean Med Sci，2012，27（9）:1044-1050.

[1]	项天乐, 周娜, 李芳, 曹梅娟. 儿童24 h活动行为测评方法研究进展[J]. 中国全科医学, 2026, 29(06): 760-766.
[2]	王立娜, 雷警输, 李奎宝, 王睿颖, 李新苗, 王芳芳, 郭晓荣, 牛瑞浩, 赵伟, 周芳芳, 赵京晶, 李忠佑. 急性心肌梗死患者炎症反应研究进展[J]. 中国全科医学, 2026, 29(06): 790-801.
[3]	史佳琦, 王玉欣, 罗佳妮, 姜琪, 吴善玉, 金头峰. 胃肠道癌症患者症状群影响因素的范围综述[J]. 中国全科医学, 2026, 29(05): 668-675.
[4]	田紫薇, 杨支兰, 赵慧敏, 翟艳萍, 李鸿雁, 杜淼, 晋源媛, 宋泽雨. 膝骨关节炎患者衰弱研究的范围综述[J]. 中国全科医学, 2026, 29(05): 676-680.
[5]	曹新阳, 汪洋, 金花, 于德华, 杨辉, 刘晓云, 许岩丽. 全科医学科研能力发展的影响因素：一项范围综述[J]. 中国全科医学, 2026, 29(04): 444-456.
[6]	周睿, 金玥, 刘婷婷, 蔡可润, 崔译元, 李思聪, 刘丽星, 冯利, 骨继发恶性肿瘤中西医结合诊疗指南工作组. 骨继发恶性肿瘤中西医结合诊疗指南[J]. 中国全科医学, 2026, 29(04): 423-435.
[7]	王艺衡, 许晓明, 夏云龙, 夏林莺, 韩雪, 郭永珍, 刘泉池, 闫文俊. 射血分数保留的心力衰竭药物治疗进展[J]. 中国全科医学, 2026, 29(03): 403-408.
[8]	中华医学会心身医学分会心身内分泌协作学组, 中华预防医学会糖尿病预防与控制专业委员会. 糖尿病共患抑郁诊疗中国专家共识[J]. 中国全科医学, 2026, 29(03): 273-292.
[9]	范学明, 杨宁宁, 郑症, 吴玉梅, 王祺. 2型糖尿病合并代谢相关脂肪性肝病患者微血管病变发生的相关因素分析及预测价值研究[J]. 中国全科医学, 2025, 28(36): 4578-4585.
[10]	刘燕, 袁艳玲, 令榕, 王兰云, 孙丽. 远程医疗在冠心病患者心脏康复中应用的范围综述[J]. 中国全科医学, 2025, 28(36): 4640-4647.
[11]	吴慧, 王绿娅, 李嘉璐, 张俊. 《纯合子家族性高胆固醇血症早期筛查与管理中国专家共识（2024年）》要点解读[J]. 中国全科医学, 2025, 28(36): 4535-4540.
[12]	王怡, 程金湘, 赵显超, 任佳封, 张丽萍, 董孟龙, 林志烽, 宿长军. 药物相关的快速眼动睡眠行为障碍研究新进展[J]. 中国全科医学, 2025, 28(35): 4511-4516.
[13]	宋欣芫, 常文秀, 张文玉, 杨婷婷, 王恺. 基于慢性肾脏病数据集的卷积神经网络对慢性肾脏病进展的预测价值研究[J]. 中国全科医学, 2025, 28(35): 4457-4463.
[14]	李明月, 汤皓晴, 郑汇娴, 张笑天, 刘晓云. 基本卫生保健质量概念内涵研究的系统综述[J]. 中国全科医学, 2025, 28(34): 4300-4310.
[15]	王梦奇, 梁墨瑄, 李泽远, 郭玉婷, 程景民. 间歇性禁食对2型糖尿病患者应用效果的范围综述[J]. 中国全科医学, 2025, 28(33): 4234-4240.